[{"id":"d08b3f2e-b940-4c34-82e7-531cd52cc0cf","acronym":"","url":"https://clinicaltrials.gov/study/NCT04401020","created_at":"2023-02-21T20:01:15.546Z","updated_at":"2024-07-02T16:35:03.034Z","phase":"Phase 1","brief_title":"First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL","source_id_and_acronym":"NCT04401020","lead_sponsor":"Sanofi","biomarkers":" BCL2 • BCL6","pipe":" | ","alterations":" BCL6 rearrangement • BCL2 rearrangement","tags":["BCL2 • BCL6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BCL6 rearrangement • BCL2 rearrangement"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SAR442257"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 47","initiation":"Initiation: 07/24/2020","start_date":" 07/24/2020","primary_txt":" Primary completion: 03/02/2024","primary_completion_date":" 03/02/2024","study_txt":" Completion: 08/14/2024","study_completion_date":" 08/14/2024","last_update_posted":"2024-05-17"}]